Klin Farmakol Farm. 2014;28(3):105-107

Essential role of vitamin D in treating osteoporosis

Petr Hrdý, Pavel Novosad
Osteocentrum, MEDIEKOS Ambulance s. r. o., Zlín

Vitamin D is one of the lipophilic vitamins that is necessary for the correct structure and function of the skeleton. From the perspective

of a specialist in clinical osteology, a reduced level of vitamin D is significant in terms of increased hazard of fall and fracture in an elderly

patient. This hazard is due to both osteoporosis and decreased function and quantity of muscle mass, i.e. sarcopenia. Sufficient

supplementation of vitamin D is one of the pharmacological goals in the care of patient with frailty syndrome. The basic discrepancy

between this syndrome and the chronological age is potential reversibility of frailty syndrome. Vitamin D and its long-term low serum

level in older age is one of the most important factors. Therapy of this deficiency is available as well as essential.

Keywords: vitamin D, frailty syndrome, osteoporosis, sarcopenia

Published: November 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrdý P, Novosad P. Essential role of vitamin D in treating osteoporosis. Klin Farmakol Farm. 2014;28(3):105-107.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2010.
    2. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692. Go to original source... Go to PubMed...
    3. Oudshoom C, Matrace Raso FU, van der Velde N, et al. Higher vitamin D serum levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25(6): 539-543. Go to original source... Go to PubMed...
    4. Gezen-Ak D, Durzun E, Ertan T, et al. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 2007; 212(3): 275-282. Go to original source... Go to PubMed...
    5. Scott D, Blizzard L, Fell J, et al. A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol 2010; 73(5): 581-587. Go to original source... Go to PubMed...
    6. Bauer MJ, Kaiser JM, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dis Assoc 2008; 9(8): 545-551. Go to original source... Go to PubMed...
    7. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010; 11(6): 391-396. Go to original source... Go to PubMed...
    8. Leng SX, Xue QL, Tian J, et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007; 55: 864-871. Go to original source... Go to PubMed...
    9. Rockwood K, Hubbard R. Frailty and the geriatrician. Age Ageing 2004; 33: 429-430. Go to original source... Go to PubMed...
    10. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 2010; 85: 752-758. Go to original source... Go to PubMed...
    11. Cranney A, Horsley T, O'Donnel S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess 2007; 158: 1-235.
    12. Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med. 2013 22; 173(8): 639-646. Go to original source... Go to PubMed...
    13. Lappe JM, Davies KM, Travers-Gustafson D, et al. Vitamin D status in a rural postmenopausal female populations. J Am Coll Nutr, 2006; 25: 393-402. Go to original source... Go to PubMed...
    14. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97: 13-19. Go to original source... Go to PubMed...
    15. van Groningen L, Opdenoordt S, van Sorge A, et al. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Europ J Endo 2010; 162: 805-811. Go to original source... Go to PubMed...
    16. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older. Lancet 2007; 370: 657-666. Go to original source... Go to PubMed...
    17. Richy F, Dukas L, Schacht E. Differential effects of D hormone analogs and native vitamin D on the risk of falls, a comparative metaanalysis. Calcif Tissue Int, 2008; 82: 102-107. Go to original source... Go to PubMed...
    18. Dukas l, Bischoff HA, Lindpainter L, et al. Alfacalcidol reduces the number of fallers in a community dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc, 2004; 52: 230-236. Go to original source... Go to PubMed...
    19. Dukas L, Schacht E, Mazor Z. Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with low creatinine clearence of less than 65 ml/min. Osteoporos Int, 2005; 16: 198-203. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.